Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.7%

3 terminated/withdrawn out of 31 trials

Success Rate

85.0%

-1.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

12%

2 of 17 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
16(59.3%)
Phase 1
8(29.6%)
Phase 2
3(11.1%)
27Total
N/A(16)
Phase 1(8)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT06322446Not ApplicableActive Not Recruiting

Exercise in People With Cystic Fibrosis on CFTR Modulator Therapy

Role: collaborator

NCT07484620Not ApplicableNot Yet Recruiting

Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease

Role: collaborator

NCT06300515Not ApplicableRecruiting

Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07448103Not ApplicableNot Yet Recruiting

Hospital and Home Rehabilitation Based on Social Care Robotics and Artificial Intelligence for Pediatric Patients

Role: collaborator

NCT06765070Not ApplicableActive Not Recruiting

Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments

Role: collaborator

NCT07159360Not ApplicableNot Yet Recruiting

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Role: collaborator

NCT02040714Enrolling By Invitation

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Role: collaborator

NCT06330311Not ApplicableCompleted

Effectiveness of Whole-Body Vibration

Role: collaborator

NCT04758533Phase 1Active Not Recruiting

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

Role: lead

NCT06167954Not ApplicableCompleted

Safety and Usability of a Robotic Gait Device for Children and Adolescents With Neurological or Neuromuscular Disease in Their Natural Environment

Role: collaborator

NCT05926635Active Not Recruiting

Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy

Role: collaborator

NCT06414850Not ApplicableCompleted

Animal-assisted Intervention in Adolescents Admitted to Acute Psychiatric Units.

Role: collaborator

NCT03157804Phase 1Completed

Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A

Role: lead

NCT05914818Not ApplicableCompleted

Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Disease

Role: collaborator

NCT02172885Phase 1Completed

Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta

Role: collaborator

NCT04465799Not ApplicableCompleted

Efficacy of ENTREN-F Program: A Psycho-family Intervention in Childhood Obesity

Role: collaborator

NCT04641767Completed

BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)

Role: collaborator

NCT04366271Phase 2Withdrawn

Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19

Role: lead

NCT02481934Phase 1Completed

Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma

Role: collaborator

NCT03624556Not ApplicableCompleted

Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)

Role: collaborator